Clinical Trial Update: Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies [Phase 4]

View source ↗

Summary

Phase 4 trial comparing ciprofloxacin to ceftazidime as empirical therapy for high-risk febrile neutropenia in children with hematologic cancers; currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Febrile Neutropenia
• Non-hodgkin Lymphoma

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)
• ceftazidime (ceftazidime)

Snippet

Sponsor: Gadjah Mada University | Conditions: Neutropenic Fever, Acute Lymphoblastic Leukemia | Phase 4 | Status: RECRUITING